Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Parathyroid hormone and vitamin D as well as the renal function test did not show any statistical difference (Tables 2 and 3, respectively).Parathyroid hormone (PTH) and Vitamin D levels of the control and BPH groupParameterMean ± SD Control groupMean ± SD Treatment group (Before: BT)Mean ± SD Treatment group (After: AT) P-valuePTH (pg/mL)45.26 ± 19.7250.68 ± 18.8749.36 ± 17.61NSVitamin D (ng/mL)30.60 ± 18.9828.55 ± 8.7032.06 ± 12.76NS n = 30; NS not significant Renal function tests of the control and BPH groupParameterMean ± SD Control groupMean ± SD Treatment group (Before: BT)Mean ± SD Treatment group (After: AT) P-valueSodium (mmol/l)140.6 ± 3.5142.8 ± 6.6142.2 ± 6.6NSPotassium (mmol/l)4.2 ± 0.54.3 ± 0.64.3 ± 0.6NSUrea (mmol/l)4.0 ± 2.34.3 ± 1.44.4 ± 1.3NSCreatinine (μmol/l)89.3 ± 23.4105.9 ± 26.5106.0 ± 26.2NS N = 30; NS not significant

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The study was a retrospective observational study.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Calcium: Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug: Croton membranaceus Müll.Arg

Observational study · BMC Complementary and Alternative Medicine · 2017

Original publication title

Calcium: Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug: Croton membranaceus Müll.Arg

George Awuku Asare; Robert A. Ngala; Daniel Afriyie; Samuel Adjei; Adriana Nyarko; Yvonne Anang-Quartey; Bernice Asiedu; Derek Doku; Brodrick Y. Amoah; Kennedy Bentum; Iddi Musah; Kensese Mossanda

© The Author(s). 2017

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Ca/Mg ratio imbalance is associated with BPH. This has previously not been demonstrated. The imbalance was significantly corrected after treatment with the phytotherapeutic drug.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Calcium (Ca): magnesium (Mg) imbalance is implicated in prostate cancer. Ca/Mg ratio increases or decreases with proliferation or apoptosis, respectively. The study examined whether this Ca/Mg imbalance exists in BPH patients and the effect of a phytotherapeutic drug on the Ca/Mg ratio.

Source: Background

Abstract: What methods does the paper describe?

Thirty (30) BPH patients who used the ethanolic root extract of Croton membranaceus (60 mg/day) for 3 months were examined for serum Ca, Mg, phosphate, parathyroid hormone (PTH), vitamin D, prostate specific antigen (PSA) levels and renal function tests (RFT) before (BT) and after treatment (AT) alongside thirty (30) controls. Twenty (20) trace element including Mg and Ca were determined in the drug by neutron activation analysis (NAA).

Source: Methods

Abstract: Results

RFT, PTH and vitamin D for BT, AT and controls (C) were normal. Mean PSA was 1.0 ± 0.64 (C), 27.9 ± 19.0 (BT) and 16.2 ± 11.8 ng/mL (AT) (p = 0.002). Mg, Ca/Mg ratio BT, AT and control were significantly different (p = 0.0001, respectively). After treatment, Mg and Ca/Mg ratio were not different from controls. The prevalence of Ca/Mg imbalance was 80% (BT), 13.3% (AT) and 3.3% (control group).

Source: Results

Abstract: Conclusion

Ca/Mg ratio imbalance is associated with BPH. This has previously not been demonstrated. The imbalance was significantly corrected after treatment with the phytotherapeutic drug.

Source: Conclusion
Authors’ abstract

Background

Calcium (Ca): magnesium (Mg) imbalance is implicated in prostate cancer. Ca/Mg ratio increases or decreases with proliferation or apoptosis, respectively. The study examined whether this Ca/Mg imbalance exists in BPH patients and the effect of a phytotherapeutic drug on the Ca/Mg ratio.

Methods

Thirty (30) BPH patients who used the ethanolic root extract of Croton membranaceus (60 mg/day) for 3 months were examined for serum Ca, Mg, phosphate, parathyroid hormone (PTH), vitamin D, prostate specific antigen (PSA) levels and renal function tests (RFT) before (BT) and after treatment (AT) alongside thirty (30) controls. Twenty (20) trace element including Mg and Ca were determined in the drug by neutron activation analysis (NAA).

Results

RFT, PTH and vitamin D for BT, AT and controls (C) were normal. Mean PSA was 1.0 ± 0.64 (C), 27.9 ± 19.0 (BT) and 16.2 ± 11.8 ng/mL (AT) (p = 0.002). Mg, Ca/Mg ratio BT, AT and control were significantly different (p = 0.0001, respectively). After treatment, Mg and Ca/Mg ratio were not different from controls. The prevalence of Ca/Mg imbalance was 80% (BT), 13.3% (AT) and 3.3% (control group).

Conclusion

Ca/Mg ratio imbalance is associated with BPH. This has previously not been demonstrated. The imbalance was significantly corrected after treatment with the phytotherapeutic drug.

Publication and source details

Original title: Calcium: Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug: Croton membranaceus Müll.Arg

George Awuku Asare; Robert A. Ngala; Daniel Afriyie; Samuel Adjei; Adriana Nyarko; Yvonne Anang-Quartey; Bernice Asiedu; Derek Doku; Brodrick Y. Amoah; Kennedy Bentum; Iddi Musah; Kensese Mossanda

BMC Complementary and Alternative Medicine · 2017

© The Author(s). 2017https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T08:14:40.483527+00:00

DOI: 10.1186/s12906-017-1663-x · PMC5346265